SCHEMBL25825374

SCHEMBL25825374

CN(C)c1ccc2nccc(Nc3ccc(C(=O)Nc4ccc(Nc5ccccc5)cc4)cn3)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 9/20 0.53
DNMT3A Q9Y6K1 7/20 0.53
DNMT3L Q9UJW3 4/20 0.53
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
HTR2C P28335 1/20 0.48
HTR2B P41595 1/20 0.48
P4HTM Q9NXG6 1/20 0.47
EHMT1 Q9H9B1 2/20 0.47
MYC P01106 1/20 0.47
MAP2K3 P46734 1/20 0.47
EHMT2 Q96KQ7 1/20 0.47
DNMT3B Q9UBC3 1/20 0.47
USP2 O75604 1/20 0.47
MAPT P10636 1/20 0.47
CSF1R P07333 2/20 0.44
AURKA O14965 1/20 0.44
AURKB Q96GD4 1/20 0.44
KCNK3 O14649 1/20 0.43
HDAC3 O15379 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30180372 0.95 DNMT1 (0.46) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL23999538 0.95 DNMT1 (0.46) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL19151414 0.93 KMT2A (0.56) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL30180285 0.93 KMT2A (0.56) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL30180590 0.90 DNMT1 (0.65) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL13335894 0.90 DNMT1 (0.65) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL23999805 0.90 KMT2A (0.47) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL30180539 0.90 DNMT1 (0.49) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL23999600 0.90 DNMT1 (0.49) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL30180432 0.90 KMT2A (0.47) DNMT1DNMT3ADNMT3LKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR DNMT1 4785/4885DNMT3A 4693/4885DNMT3L 4461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.